The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

The United States Food and Drug Administration (FDA) has approved Spravato (esketamine), a nasal spray from Johnson & Johnson, as a stand-alone therapy for adults with major depressive disorder ...

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

We can help. Stella Mental Health in New York specializes in Spravato (esketamine) nasal spray, ketamine infusion therapy, stellate ganglion blocks (SGB) and integration therapy. Schedule an ...

EAST PEORIA ( 25News Now) - Ketamine therapy is becoming a more popular treatment for resistant mental health disorders, and a treatment center owner in East Peoria said the practice can change lives, ...